M3J-25745-21539
3 vaccinations
1 coded response
26 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 407 / KY
- Registered
- 2021-08-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
EE7-70176-27747
Child or adolescent in my care · Female · 2022-08-16
Timeline
-
2021-08-13
Registered in v-safe
-
2021-08-14
Dose 1 — Pfizer-BioNTech
- 2021-08-14
-
2021-08-15
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-08-16
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work or attend schoolAdult check-in
-
2021-08-17
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-08-18
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness, NauseaAdult check-in
- 2021-08-19
- 2021-08-20
- 2021-08-21
-
2021-08-28
Survey response — day 14, dose 1MedDRA: Headache, Nausea, Presyncope — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Nausea, headache, near syncope.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-04
Dose 2 — Pfizer-BioNTech
-
2021-09-04
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
-
2021-09-05
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-09-06
-
2021-09-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness, Abdominal painAdult check-in
-
2021-09-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness, Nausea, Abdominal painAdult check-in
- 2021-09-09
- 2021-09-10
- 2021-09-11
- 2021-09-18
- 2021-09-25
- 2021-10-02
- 2021-10-09
- 2021-10-16
- 2021-12-04
- 2022-03-05
- 2022-09-04
-
2023-02-14
Dose 3 — Pfizer-BioNTechCo-administered: Other
- 2023-03-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-14 | Pfizer-BioNTech | No |
| 2 | 2021-09-04 | Pfizer-BioNTech | No |
| 3 | 2023-02-14 | Pfizer-BioNTech | Other |
Free text
Release 9 — day 14, dose 1
Symptoms: Nausea, headache, near syncope.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | ✓ | · | ✓ |
| SD | Nausea | ✓ | · | ✓ |
| SD | Presyncope | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release